Todas as matérias desta seção, das mais recentes às mais antigas — página 249 de 371.
Canadian Solar (NASDAQ:CSIQ) reported its fourth-quarter and full-year 2025 financial results on March 19, 2026, highlighting a year of strategic transition toward high-growth energy storage and localized U.S. manufacturing.
ZKH Group (NYSE:ZKH), a leading digitalized industrial maintenance, repair, and operations (MRO) procurement platform in China, reported its unaudited financial results for the fourth quarter and full year ended December 31, 2025.
Duluth Holdings (NASDAQ:DLTH) reported a marked improvement in its financial health for the fourth quarter and full fiscal year ended February 1, 2026.
Shell (NYSE:SHEL) provided a critical update on its operations in Qatar following a series of security incidents at the Ras Laffan Industrial City.
Alibaba Group Holding (NYSE:BABA) announced its financial results for the quarter ended December 31, 2025, revealing a strategic pivot toward reinvestment and market share defense.
Evotec (NASDAQ:EVO) announced today that it will receive a $10 million milestone payment from Bristol Myers Squibb (NYSE:BMY) following the start of a Phase 1 clinical trial for BMS-986506.
Almonty Industries (NASDAQ:ALM) announced its financial results for the fourth quarter and full fiscal year ended December 31, 2025, highlighting a period of extreme valuation growth and strategic positioning.
Sunlands Technology Group (NYSE:STG) announced its unaudited financial results for the fourth quarter and full year ended December 31, 2025, revealing a strategic transition from rapid scale to a quality-driven operational model.
UP Fintech Holding (NASDAQ:TIGR), known globally as Tiger Brokers, reported stellar financial results for the fourth quarter and full fiscal year ended December 31, 2025.
LexinFintech Holdings (NASDAQ:LX) today announced its unaudited financial results for the fourth quarter and full fiscal year ended December 31, 2025.
KYO Pharma (NASDAQ:OKYO) reported new exploratory Phase 2a findings for its lead candidate, urcosimod (0.05%), demonstrating that the topical therapy significantly improves the quality of life (QoL) for patients suffering from neuropathic corneal pain (NCP).
Aclaris Therapeutics (NASDAQ:ACRS) announced it has successfully completed patient enrollment for its Phase 2 clinical trial of bosakitug (ATI-045), an investigational treatment for patients suffering from moderate-to-severe atopic dermatitis.
H World Group (NASDAQ:HTHT) reported strong unaudited financial results for the fourth quarter and full year ended December 31, 2025, underscored by significant portfolio growth and aggressive capital return programs.
General Mills (NYSE:GIS) reported a sharp decline in its third-quarter financial results for the period ended February 22, 2026, as the consumer foods giant navigates a complex portfolio restructuring and rising operational costs.
Ovid Therapeutics (NASDAQ:IVID) announced a $60 million private placement to fund the expansion of its clinical pipeline into tuberous sclerosis complex seizures and infantile spasms.
Yuanbao (NASDAQ:YB) reported its unaudited financial results for the fourth quarter and full year ended December 31, 2025, delivering a masterclass in high-growth, high-margin fintech execution.
Weibo (NASDAQ:WB) announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025, demonstrating the platform's enduring position as China’s leading social media hub for real-time content.
Five Below (NASDAQ:FIVE) reported stellar financial results for the fourth quarter and fiscal year ended January 31, 2026, showcasing the strength of its high-growth value retail model.
Micron Technology (NASDAQ:MU) reported record-breaking financial results for its fiscal second quarter ended February 26, 2026, as the company continues to capitalize on the unprecedented demand for memory and storage solutions sparked by artificial intelligence.
FedEx (NYSE:FDX) has initiated the final phase of its multi-year operational overhaul, announcing plans to close nine shipping facilities across New York and one in Pennsylvania.
Arvinas (NASDAQ:ARVN) today presented positive data from its Phase 1 clinical trial of ARV-102, an investigational oral PROTAC (PROteolysis TArgeting Chimera) designed to treat neurodegenerative diseases.
Neonode (NASDAQ:NEON) reported its financial results for the fiscal year ended December 31, 2025, characterized by a strategic shift in its technology portfolio and a significant non-recurring capital injection.
SailPoint Technologies (NASDAQ:SAIL) announced financial results for its fourth quarter and full fiscal year ended January 31, 2026, marking a significant milestone as the company surpassed $1 billion in annual revenue.
Nvidia (NASDAQ:NVDA) has begun restarting its manufacturing lines for H200 processors destined for the Chinese market, according to CEO Jensen Huang.
